These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29050839)

  • 1. Recommendations by the Spanish Society of Rheumatology on the Use of Biological Therapies in Axial Spondyloarthritis.
    Gratacós J; Díaz Del Campo Fontecha P; Fernández-Carballido C; Juanola Roura X; Linares Ferrando LF; de Miguel Mendieta E; Muñoz Fernández S; Rosales-Alexander JL; Zarco Montejo P; Guerra Rodríguez M; Navarro Compán V
    Reumatol Clin (Engl Ed); 2018; 14(6):320-333. PubMed ID: 29050839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in spondyloarthritis except for psoriatic arthritis].
    Juanola Roura X; Zarco Montejo P; Sanz Sanz J; Muñoz Fernández S; Mulero Mendoza J; Linares Ferrando LF; Gratacós Masmitja J; García de Vicuña R; Fernandez Carballido C; Collantes Estevez E; Batlle Gualda E; Ariza Ariza R; Loza Santamaría E
    Reumatol Clin; 2011; 7(2):113-23. PubMed ID: 21794794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2014 update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological therapies in rheumatoid arthritis.
    Sanmartí R; García-Rodríguez S; Álvaro-Gracia JM; Andreu JL; Balsa A; Cáliz R; Fernández-Nebro A; Ferraz-Amaro I; Gómez-Reino JJ; González-Álvaro I; Martín-Mola E; Martínez-Taboada VM; Ortiz AM; Tornero J; Marsal S; Moreno-Muelas JV
    Reumatol Clin; 2015; 11(5):279-94. PubMed ID: 26051464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations of the Spanish Society of Rheumatology on treatment and use of systemic biological and non-biological therapies in psoriatic arthritis.
    Torre Alonso JC; Díaz Del Campo Fontecha P; Almodóvar R; Cañete JD; Montilla Morales C; Moreno M; Plasencia-Rodríguez C; Ramírez García J; Queiro R
    Reumatol Clin (Engl Ed); 2018; 14(5):254-268. PubMed ID: 29111261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis - 2016 update.
    Machado P; Cerqueira M; Ávila-Ribeiro P; Aguiar R; Bernardo A; Sepriano A; Águeda A; Cordeiro A; Raposo A; Rodrigues AM; Barcelos A; Malcata A; Lopes C; Vaz CC; Nour D; Godinho F; Alvarenga F; Pimentel-Santos F; Canhão H; Santos H; Cunha I; Neves JS; Fonseca JE; Gomes JL; Tavares-Costa J; Costa L; Cunha-Miranda L; Maurício L; Cruz M; Afonso MC; Santos MJ; Bernardes M; Valente P; Figueira R; Pimenta S; Ramiro S; Pedrosa T; Costa TA; Vieira-Sousa E
    Acta Reumatol Port; 2017; 42(3):209-218. PubMed ID: 28894079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis.
    Bautista-Molano W; Fernández-Ávila DG; Brance ML; Ávila Pedretti MG; Burgos-Vargas R; Corbacho I; Cosentino VL; Díaz Coto JF; Giraldo Ho E; Gomes Resende G; Gutiérrez LA; Gutiérrez M; Ibáñez Vodnizza SE; Jáuregui E; Ocampo V; Palleiro Rivero DR; Palominos PE; Pacheco Tena C; Quiceno GA; Saldarriaga-Rivera LM; Sommerfleck FA; Goecke Sariego A; Vera Barrezueta C; Vega Espinoza LE; Vega Hinojosa O; Citera G; Lozada C; Sampaio-Barros PD; Schneeberger E; Soriano ER
    Nat Rev Rheumatol; 2023 Nov; 19(11):724-737. PubMed ID: 37803079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on recommendations for eligibility of government subsidization of biologic disease-modifying antirheumatic drugs for the treatment of axial spondyloarthritis in Singapore.
    Phang KF; Lahiri M; Fong WWS; Leong KH; Leung YY; Lim AYN; Lui NL; Manghani M; Tan TC; Santosa A; Sriranganathan MK; Suresh E; Teng GG; Cheung PP
    Int J Rheum Dis; 2020 Feb; 23(2):165-173. PubMed ID: 31762225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Consensus statement of the Spanish Society of Rheumatology on the management of biologic therapies in psoriatic arthritis].
    Fernández Sueiro JL; Juanola Roura X; Cañete Crespillo Jde D; Torre Alonso JC; García de Vicuña R; Queiro Silva R; Ariza Ariza R; Batlle Gualda E; Loza Santamaría E;
    Reumatol Clin; 2011; 7(3):179-88. PubMed ID: 21794810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Consensus statement of the Spanish Society of Rheumatology on risk management of biologic therapy in rheumatic patients].
    Gómez Reino J; Loza E; Andreu JL; Balsa A; Batlle E; Cañete JD; Collantes Estévez E; Fernández Carballido C; Fernández Sueiro JL; García de Vicuña R; González-Álvaro I; González Fernández C; Juanola X; Linares LF; Marenco JL; Martín Mola E; Moreno Ramos M; Mulero Mendoza J; Muñoz Fernández S; Queiro R; Richi Alberti P; Sanz J; Tornero Molina J; Zarco Montejo P; Carmona L;
    Reumatol Clin; 2011; 7(5):284-98. PubMed ID: 21925444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2018 APLAR axial spondyloarthritis treatment recommendations.
    Tam LS; Wei JC; Aggarwal A; Baek HJ; Cheung PP; Chiowchanwisawakit P; Dans L; Gu J; Hagino N; Kishimoto M; Reyes HM; Soroosh S; Stebbings S; Whittle S; Yeap SS; Lau CS
    Int J Rheum Dis; 2019 Mar; 22(3):340-356. PubMed ID: 30816645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis--December 2011 update.
    Machado P; Bernardo A; Cravo AR; Rodrigues A; Malcata A; Nour D; Vieira-Sousa E; Godinho F; Pimentel F; Canhão H; Santos H; Cunha I; Fonseca JE; Costa J; Costa L; Cunha-Miranda L; Maurício L; Cruz M; Santos MJ; Bernardes M; Bogas M; Valente P; Ramiro S; Barcelos A;
    Acta Reumatol Port; 2012; 37(1):40-7. PubMed ID: 22781513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taiwan Rheumatology Association consensus recommendations for the management of axial spondyloarthritis.
    Wei JC; Liu CH; Tseng JC; Hsieh LF; Chen CH; Chen HH; Chen HA; Chen YC; Chou CT; Liao HT; Lin YC; Luo SF; Yang DH; Yeo KJ; Tsai WC;
    Int J Rheum Dis; 2020 Jan; 23(1):7-23. PubMed ID: 31777200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remission in axial spondyloarthritis: Developing a consensus definition.
    Fernández-Carballido C; Collantes-Estévez E; Gratacós J; Juanola X; Zarco P
    Reumatol Clin (Engl Ed); 2021; 17(7):380-387. PubMed ID: 34301380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Brazilian Society of Rheumatology guidelines for axial spondyloarthritis - 2019.
    Resende GG; Meirelles ES; Marques CDL; Chiereghin A; Lyrio AM; Ximenes AC; Saad CG; Gonçalves CR; Kohem CL; Schainberg CG; Campanholo CB; Bueno Filho JSS; Pieruccetti LB; Keiserman MW; Yazbek MA; Palominos PE; Goncalves RSG; Lage RDC; Assad RL; Bonfiglioli R; Anti SMA; Carneiro S; Oliveira TL; Azevedo VF; Bianchi WA; Bernardo WM; Pinheiro MM; Sampaio-Barros PD
    Adv Rheumatol; 2020 Feb; 60(1):19. PubMed ID: 32171329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
    Malaviya AN; Kalyani A; Rawat R; Gogia SB
    Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis.
    Deodhar A; Strand V; Kay J; Braun J
    Ann Rheum Dis; 2016 May; 75(5):791-4. PubMed ID: 26768406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consensus statement on the investigation and management of non-radiographic axial spondyloarthritis (nr-axSpA).
    Robinson PC; Bird P; Lim I; Saad N; Schachna L; Taylor AL; Whittle SL; Brown MA
    Int J Rheum Dis; 2014 Jun; 17(5):548-56. PubMed ID: 24673897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for acquisition and interpretation of MRI of the spine and sacroiliac joints in the diagnosis of axial spondyloarthritis in the UK.
    Bray TJP; Jones A; Bennett AN; Conaghan PG; Grainger A; Hodgson R; Hutchinson C; Leandro M; Mandl P; McGonagle D; O'Connor P; Sengupta R; Thomas M; Toms A; Winn N; Hall-Craggs MA; Marzo-Ortega H; Machado PM;
    Rheumatology (Oxford); 2019 Oct; 58(10):1831-1838. PubMed ID: 31046100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of SpondyloArthritis International Society (ASAS) Consensus on Spanish Nomenclature for Spondyloarthritis.
    Navarro-Compán V; Otón T; Loza E; Almodóvar R; Ariza-Ariza R; Bautista-Molano W; Burgos-Vargas R; Collantes-Estévez E; de Miguel E; González-Fernández C; Gratacós J; Ibáñez S; Juanola X; Maldonado-Cocco J; Moltó A; Mulero J; Pacheco-Tena C; Ramos-Remus C; Sanz-Sanz J; Valle-Oñate R; Zarco P; Marzo-Ortega H
    Reumatol Clin (Engl Ed); 2020; 16(5 Pt 1):333-338. PubMed ID: 30193774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canadian Rheumatology Association Consensus on the use of anti-tumor necrosis factor-alpha directed therapies in the treatment of spondyloarthritis.
    Maksymowych WP; Inman RD; Gladman D; Thomson G; Stone M; Karsh J; Russell AS;
    J Rheumatol; 2003 Jun; 30(6):1356-63. PubMed ID: 12784417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.